# Unified Field Theory of Research Inequity

In meta-research synthesis, does the convergence of multiple analytical dimensions into a unified framework reveal the magnitude of clinical research inequity facing Africa? This meta-audit integrated trial volume (23,873 African versus 190,644 United States), condition coverage (twenty diseases), design features (twelve categories), temporal trends (five epochs), and geographic distribution (53 active countries) from ClinicalTrials.gov into a composite inequity score. The unified score was computed as the average normalised deficit across all dimensions. Africa scored ninety-four on a hundred-point composite inequity index, indicating near-total structural disadvantage across every evaluated dimension from volume to governance to methodology. The Gini coefficient of 0.857 for trial distribution, the 6x Europe-Africa volume gap, and the 41x immunotherapy deficit all converge on a single conclusion of systemic exclusion. These findings demonstrate that research equity requires fundamental reorganisation rather than marginal adjustment. Interpretation is limited by the rapidly evolving nature of global health policy.

## References

1. Alemayehu C, et al. "Behind the mask of the African clinical trials landscape." Trials. 2018;19:519.
2. Ndounga Diakou LA, et al. "Mapping of clinical trials in sub-Saharan Africa." Trials. 2022;23:490.
3. Drain PK, et al. "Global migration of clinical trials." Nat Rev Drug Discov. 2018;17:765-766.

## Note Block

- Type: research
- App: https://mahmood726-cyber.github.io/africa-e156-students/governance-justice/dashboards/unified-theory.html
- Code: https://github.com/mahmood726-cyber/africa-e156-students/blob/master/governance-justice/code/unified-theory.py
- Data: ClinicalTrials.gov API v2
- Date: 2026-04-05